Amundi obtains regulatory approval for ICG board seat and will consolidate its stake using the equity method as from 31 March 2026
Amundi announces that it has obtained all regulatory approvals for ICG to appoint an Amundi‑nominated director to its Board.
Vincent Mortier, Amundi’s Group Chief Investment Officer, will join the Board of ICG as a Non‑Executive Director on 31 March 2026. He will also serve as a member of ICG’s Board Nomination and Governance Committee.
As a consequence, Amundi will consolidate its stake in ICG using the equity method as from 31 March 2026.
In accordance with the partnership announced on 18 November 2025, Amundi currently holds a 4.64% stake in ICG and intends to increase its economic interest to 9.9%, through the issuance of non-voting shares by ICG to Amundi[1].
[1] In order to offset the dilution arising from this issuance, ICG will undertake an on-market share buyback of its ordinary shares